These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 38004713)
21. Epidemiological characteristics, clinical manifestations, and mental health status of human mpox cases: A multicenter cross-sectional study in China. Fu L; Wang B; Wu K; Yang L; Hong Z; Wang Z; Meng X; Ma P; Qi X; Xu G; Wang F; Zhang W; Huang C; Zhang D; Lin Y; Cao W; Sun P; Wu W; Gao Y; Lv F; Qian J; Lu H; Zou H J Med Virol; 2023 Oct; 95(10):e29198. PubMed ID: 37881113 [TBL] [Abstract][Full Text] [Related]
22. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States. Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon KS; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg MJ; Skarbinski J; Leyden WA; Williams CF; Althoff KN; JAMA Netw Open; 2022 Jun; 5(6):e2215934. PubMed ID: 35671054 [TBL] [Abstract][Full Text] [Related]
23. Clinical manifestations and viral kinetics of people with Mpox: A case series during the 2023 outbreak in Taiwan. Chen KH; Liu WD; Weng KC; Chen HH; Ho SY; Huang YS; Wu TY; Li GC; Chang SY; Hung CC J Microbiol Immunol Infect; 2024 Aug; ():. PubMed ID: 39227237 [TBL] [Abstract][Full Text] [Related]
24. Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics. Candela C; Raccagni AR; Bruzzesi E; Bertoni C; Rizzo A; Gagliardi G; Canetti D; Gianotti N; Mileto D; Gismondo MR; Castagna A; Nozza S; Viruses; 2023 Mar; 15(3):. PubMed ID: 36992376 [TBL] [Abstract][Full Text] [Related]
26. Mpox across countries from Central and Eastern Europe - 2022 outbreak. Ianache I; Skrzat-Klapaczynska A; Jilich D; Fleischhans L; Gmizic I; Ranin J; Papadopoulos A; Protopapas K; Mulabdic V; Lakatos B; Nagy EL; Begovac J; Holban T; Sevgi DY; Cicic A; Yancheva N; Sojak L; Rukhadze N; Kowalska J; Oprea C; Travel Med Infect Dis; 2024; 59():102719. PubMed ID: 38574784 [TBL] [Abstract][Full Text] [Related]
27. A Microsimulation Model of Mpox in Los Angeles County: Implications for Future Disease Prevention and Control Strategies among Men Who Have Sex with Men. Liang C; Suen SC; Hong C; Kim A; Singhal R; Simon P; Perez M; Holloway IW Open Forum Infect Dis; 2024 Oct; 11(Suppl 2):S137-S145. PubMed ID: 39415828 [TBL] [Abstract][Full Text] [Related]
28. Long or complicated mpox in patients with uncontrolled HIV infection. Corma-Gómez A; Cabello A; Orviz E; Morante-Ruiz M; Ayerdi O; Al-Hayani A; Muñoz-Gómez A; Santos IL; Gómez-Ayerbe C; Rodrigo D; Riestra SR; Reus-Bañuls S; Silva-Klug A; Galindo MJ; Santos M; Serrano-Fuentes M; Faro-Míguez N; Pérez-Camacho I; Corona-Mata D; Morano L; López-Ruz MÁ; Montero M; Anaya-Baz B; Merino D; Castillo-Navarro A; Pineda JA; Macías J J Med Virol; 2024 Mar; 96(3):e29511. PubMed ID: 38469884 [TBL] [Abstract][Full Text] [Related]
29. Disparities in Mpox Vaccination Among Priority Populations During the 2022 Outbreak. Alavian N; Mourad A; Woodhouse EW; Niehaus E; Cunningham H; Zavala S; Kohler P; Pappas S; Yarrington ME; Okeke NL; Wolfe CR; Cox GM; Dicks KV; Stout JE Open Forum Infect Dis; 2023 Sep; 10(9):ofad434. PubMed ID: 37662451 [TBL] [Abstract][Full Text] [Related]
30. Features of Mpox infection: The analysis of the data submitted to the ID-IRI network. Eser-Karlidag G; Chacon-Cruz E; Cag Y; Martinez-Orozco JA; Gudino-Solorio H; Cruz-Flores RA; Gonzalez-Rodriguez A; Martinez-Nieves D; Gomez-Zepeda M; Calderon-Suarez A; Çaşkurlu H; Cascio A; Fernandez R; Gonzales GM; Palma P; Popescu CP; Stebel R; Lakatos B; Nagy E; Lanzafame M; El-Kholy A; Tuncer B; Christova I; Krumova S; Barbosa AN; Escalera-Antezana JP; Castillo-Quino R; Gonzales-Flores CE; Moreira-Flores M; Batallanos-Huarachi MF; Gomez-Davila C; Baljic R; Vieceli T; Ariyo OE; Llobell MC; Gideon OO; Osborne A; Elbahr U; Bossi P; Tammaro A; Rodriguez-Morales AJ; Erdem H New Microbes New Infect; 2023 Jun; 53():101154. PubMed ID: 37260588 [TBL] [Abstract][Full Text] [Related]
31. Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US. Lang R; Humes E; Coburn SB; Horberg MA; Fathi LF; Watson E; Jefferson CR; Park LS; Gordon KS; Akgün KM; Justice AC; Napravnik S; Edwards JK; Browne LE; Agil DM; Silverberg MJ; Skarbinski J; Leyden WA; Stewart C; Hogan BC; Gebo KA; Marconi VC; Williams CF; Althoff KN; JAMA Netw Open; 2022 Oct; 5(10):e2236397. PubMed ID: 36227594 [TBL] [Abstract][Full Text] [Related]
32. Clinical Presentation of Mpox in People With and Without HIV in the United Kingdom During the 2022 Global Outbreak. Pilkington V; Quinn K; Campbell L; Payne L; Brady M; Post FA AIDS Res Hum Retroviruses; 2023 Nov; 39(11):581-586. PubMed ID: 37071153 [TBL] [Abstract][Full Text] [Related]
33. Mpox outbreak 2022: an overview of all cases reported to the Cologne Health Department. Kröger ST; Lehmann MC; Treutlein M; Fiethe A; Kossow A; Küfer-Weiß A; Nießen J; Grüne B Infection; 2023 Oct; 51(5):1369-1381. PubMed ID: 36787016 [TBL] [Abstract][Full Text] [Related]
34. Mpox Incidence and Vaccine Uptake in Men Who Have Sex with Men and Are Living with HIV in Denmark. Svartstein AW; Knudsen AD; Heidari SL; Heftdal LD; Gelpi M; Benfield T; Nielsen SD Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514983 [TBL] [Abstract][Full Text] [Related]
36. Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score-Matched Analysis. Nomah DK; Díaz Y; Bruguera A; Moreno-Fornés S; Aceiton J; Reyes-Urueña J; Llibre JM; Falcó V; Imaz A; Fanjul FJ; Peraire J; Deig E; Domingo P; Inciarte A; Casabona J; Miró JM Open Forum Infect Dis; 2024 Jan; 11(1):ofad693. PubMed ID: 38221982 [TBL] [Abstract][Full Text] [Related]
37. The effect of HIV and mpox co-infection on clinical outcomes: Systematic review and meta-analysis. Taha AM; Elrosasy A; Mahmoud AM; Saed SAA; Moawad WAE; Hamouda E; Nguyen D; Tran VP; Pham HT; Sah S; Barboza JJ; Sah R HIV Med; 2024 Aug; 25(8):897-909. PubMed ID: 38443319 [TBL] [Abstract][Full Text] [Related]
38. Epidemiologic and Clinical Features of Mpox in Adults Aged >50 Years - United States, May 2022-May 2023. Eustaquio PC; Salmon-Trejo LAT; McGuire LC; Ellington SR MMWR Morb Mortal Wkly Rep; 2023 Aug; 72(33):893-896. PubMed ID: 37590262 [TBL] [Abstract][Full Text] [Related]
39. Mpox vaccination for men who have sex with men and their differential risk of exposure and infection. Wong NS; Wong BC; Lee MP; Tsang OT; Cheung DKF; Sit AY; Wong SY; Lee SS Hum Vaccin Immunother; 2023 Aug; 19(2):2252263. PubMed ID: 37649367 [TBL] [Abstract][Full Text] [Related]
40. Low CD4 Count or Being Out of Care Increases the Risk for Mpox Hospitalization Among People With Human Immunodeficiency Virus and Mpox. Philpott DC; Bonacci RA; Weidle PJ; Curran KG; Brooks JT; Khalil G; Feldpausch A; Pavlick J; Wortley P; O'Shea JG Clin Infect Dis; 2024 Mar; 78(3):651-654. PubMed ID: 37590957 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]